Brendan Parent

JD
NYU Langone Health
Brendan Parent

Brief Bio

Brendan Parent, JD, is director of transplant ethics and policy research and assistant professor of bioethics in the division of medical ethics with joint appointment in surgery at NYU Grossman School of Medicine. He serves as an independent living donor advocate and provides ethics consultation for transplant programs across the United States. He is editor-in-chief of the Health Law Journal for the New York State Bar Association, a fellow of the Center for Genetics and Society, and a member of the Tri-SCI embryonic stem cell research oversight committee. In addition to transplant ethics, Parent’s current work focuses on ethics of crisis resource allocation, ethical challenges surrounding big data and artificial intelligence in health research, and regulation of emerging medical technologies. He has published academic articles in peer reviewed journals spanning law, medicine, science, sports, and ethics, and his work has been featured in the Washington Post, The NY Times, Chicago Tribune, The Guardian, and on NPR. Previously, he was a legal fellow for the New York Task Force on Life and the Law, the first Rudin Post-Doc in the NYU Division of Medical Ethics, and received his JD from Georgetown University Law Center.

Alliance Presentations

Medical Legal

Understanding the UDDA: A Review of the Legal Standard of Death Determination

Tuesday, November 29, 2022, at 2:00pm

The Uniform Determination of Death Act, (“UDDA”) which is currently the law in most states holds that in order to be determined deceased an individual must present irreversible cession of cardiorespiratory function or irreversible cessation of all functions of the entire brain, including the brain stem. However, inconsistencies identified between the clinical protocols to declare brain death and the legal wording has led to discussions suggesting that action should be taken to revise and clarify the legal standard of death determination. Given that most deceased donations result from patients declared dead by neurologic criteria, this ongoing deliberation is important to the donation and transplantation community, and other constituents in the continuum of care, including patients. For this discussion, we will be joined by Christina Strong, JD. and Brendan Parent, JD who will provide further information about the proposals being made to help us better understand the rationale behind these changes from the legal and ethical perspective.

NRP AS 325141580

A Comparative Philosophical Perspective on The Ethics of Normothermic Regional Perfusion

Tuesday, December 06, 2022, at 12:00pm

The Alliance Conversation Series brings you cost-free, fast-paced collaborative opportunities that highlight successful donation and transplantation practices across the country. Through shared insight, multidisciplinary experts identify solutions to critical challenges affecting the community of practice and actively share them for open discussion and broader knowledge of effective practices.

The Alliance is not an advocacy organization and always intends to maintain an objective and unbiased perspective.

Sessions are designed to be approximately 30-45 minutes in length and encourage real-time feedback and participation from viewers.

Overview: Expanding donation after circulatory of death (DCD) is a critical route to addressing the shortage of organs for transplant, and in-situ normothermic regional perfusion (NRP) holds promise for providing optimal DCD organ recovery outcomes. While this mode of recovery is well-established in some jurisdictions, there remain significant ethical concerns related to whether this method undermines the determination of death. This session will explore the ethical arguments for and against DCD NRP comparing international contexts, and with specific attention to the rights and interests of potential donors and authorizing family members.

HospitalSign SM 24794807

Improving Access to Transplant Care for Communities of Color

Tuesday, February 22, 2022, at 3:00pm

Reducing health disparities to improve life-saving donations and advance organ transplantation is a critical step in advancing equity within healthcare. Over the course of this discussion, we will explore the hidden barriers that exist in the transplant evaluation process that prevents communities of color from receiving access to appropriate medical care and transplantation. Our panelists will explore effective measures that transplant programs can take to increase the rate of transplants for racially diverse patients and improve healthcare equity.

Lifelong Networks

Our partners are the heart and soul of our organization. For more than 15 years, they have played a vital role providing quality education and programs to advance a shared mission.